Clinical Trials on Metastatic Rectum Cancer in Switzerland

Total 957 results

Matthias Guckenberger

Recruiting

Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial Metastases

Metastatic Cancer

Switzerland
University Hospital, Geneva

Recruiting

Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer (PEMREC)

Rectal Cancer | Rectum Cancer

Switzerland
Amal Therapeutics
Boehringer Ingelheim

Active, not recruiting

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

Metastatic Colorectal Cancer | Colorectal Cancer | Liver Metastasis Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | MSS

United States, Belgium, Switzerland, Germany
Kantonsspital Winterthur KSW

Recruiting

Long-term Cohort Study of Mesorectal Excision for Rectal Cancer (TME-KSW)

Cancer | Rectum

Switzerland
Centre Hospitalier Universitaire Vaudois

Unknown

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Colorectal Cancer | Metastatic Cancer

Switzerland
University Hospital, Basel, Switzerland

Not yet recruiting

Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)

Advanced Solid Tumor

Switzerland
University of Zurich

Unknown

Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

Breast Cancer | Metastatic Neoplasm | ERBB2

Switzerland
University of Lausanne Hospitals
University Hospital, Zürich; Cantonal Hospital of St. Gallen

Completed

[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging

Metastatic Ovarian Cancer | Metastatic Cancer Lung

Switzerland
Sara De Dosso
Clinical Trial Unit Ente Ospedaliero Cantonale; Istituto Cantonale di Patologia

Completed

A Retrospective Study Project of Clinico-molecular Characterization in Patients With Metastatic Colorectal Cancer

Mestastatic ColoRectal Cancer

Switzerland
European Organisation for Research and Treatment...

Terminated

Adjuvant Radiation Therapy in Treating Patients With Brain Metastases

Metastatic Cancer

France, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
Patrick Veit-Haibach
Roche Pharma AG

Terminated

Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) (AVA-CTP)

Metastatic Colorectal Cancer

Switzerland
Amgen
Roche-Genentech

Completed

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

Metastatic Colorectal Cancer | Metastatic Triple Negative Breast Cancer

United States, Belgium, Spain, Australia, Switzerland, Germany
Dimitri Christoforidis
Clinical Trial Unit Ente Ospedaliero Cantonale

Terminated

Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test. (LiBReCa)

Locally Advanced Rectal Cancer

Switzerland
Thomas Zilli
University Hospital, Geneva

Terminated

Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy

Rectal Cancer | Advanced Cancer | Rectal Tumors

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Cetuximab for Elderly Patients With mCRC

Metastatic Colorectal Cancer

Switzerland
Luzerner Kantonsspital

Recruiting

Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion

Lung Cancer | Lymph Node Metastasis

Switzerland
University of Zurich
Swiss Federal Institute of Technology; Swiss Academy of Medical Sciences (SAMS)

Unknown

Mobile Health Technology for Palliative Care Patients

Chronic Disease | Metastatic Cancer | Mobile Health

Switzerland
European Organisation for Research and Treatment...
Roche Pharma AG; Amgen

Terminated

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases (BOS2)

Colorectal Cancer Metastatic | Liver Metastases | KRAS Wild Type Colorectal Cancer

France, Belgium, Austria, Netherlands, Spain, Switzerland
Kantonsspital Graubünden
Janssen-Cilag Ltd.

Completed

Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients (MetAb-Pro)

Metastatic Prostate Cancer

Switzerland
University Ghent
University Hospital, Geneva

Active, not recruiting

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic Cancer

Norway, Spain, Belgium, Switzerland, Australia, Italy
Centre Hospitalier Universitaire Vaudois

Unknown

Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer

Colorectal Cancer

Switzerland
Ipsen

Terminated

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Gastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic Tumours

United States, France, Belgium, Switzerland, Netherlands
Kantonsspital Graubuenden
Swiss Group for Clinical Cancer Research

Completed

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Prostate Cancer | Prostate Cancer Recurrent | Lymph Node Metastases

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation

Completed

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Prostate Cancer | Bladder Cancer

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy (PRESERVE)

Rectal Cancer

Switzerland
St. Claraspital AG

Withdrawn

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

Rectal Cancer

Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer (ITB)

CRC

Switzerland
University of Lausanne Hospitals

Unknown

Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging

Rectal Cancer

Switzerland
University Hospital Inselspital, Berne

Completed

Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer

Rectal Cancer

Switzerland
AO Innovation Translation Center
AO Foundation, AO Spine

Recruiting

Metastatic Tumor Research and Outcomes Network (MTRON)

Metastatic Spine Tumor

United States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy

Metastatic Colorectal Cancer

Switzerland, Austria
University Hospital, Basel, Switzerland

Terminated

Quality of Life in Patients With Rectal Cancer Receiving Total Mesorectal Excision With or Without Stoma

Rectal Cancer

Switzerland
Hoffmann-La Roche
Sanofi

Completed

An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer

Colorectal Cancer

Switzerland
European Organisation for Research and Treatment...

Terminated

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Metastatic Cancer | Intraocular Melanoma

Switzerland, Italy, United Kingdom, Poland
University Hospital, Basel, Switzerland

Recruiting

Circulating Tumor Cells (CTC) in Cancer

Cancer

Switzerland
Ente Ospedaliero Cantonale, Bellinzona

Completed

Efficacy of Ondansetron in LARS Treatment (Hodolar)

Rectal Cancer

Switzerland
Kantonsspital Liestal

Terminated

Closure of Protective Ileostomy 2 vs. 12 Weeks After TME (Closure2vs12)

Rectal Cancer

Switzerland
University Hospital, Basel, Switzerland
St. Clara Research Ltd.

Terminated

Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.

Metastatic Pancreatic Cancer

Switzerland
David Palma
London Health Sciences Centre; Amsterdam University Medical Centre, VUmc Site; British Columbia Cancer - Centre for the North and other collaborators

Active, not recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)

Metastatic Tumors

United Kingdom, Canada, Switzerland, Netherlands, Australia
Servier Affaires Médicales

Active, not recruiting

Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective (PROMETCO)

Metastatic Colorectal Cancer

Netherlands, Belgium, Spain, France, Italy, Sweden, Slovenia, Germany, Argentina, Austria, Croatia, Czechia, Greece, Hungary, Ireland, Portugal, Switzerland, United Kingdom
Incyte Biosciences International Sàrl

Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

Metastatic Cancer | Advanced Malignancies

United States, United Kingdom, Spain, Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Metastatic Breast Cancer | Bone Metastases | Metastatic Prostate Cancer

Switzerland, Germany, Austria
Ipsen

Terminated

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) (SSTR2+)

Small Cell Lung Cancer and Breast Cancer

United States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
University Hospital, Basel, Switzerland
Sanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer League

Completed

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma (GEMOXEL)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Switzerland
Terumo Europe N.V.

Completed

Holmium-166 Retrospective Collection of Real-World Data (RECORD)

Hepatocellular Carcinoma | Metastatic Cancer

Netherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
Cantonal Hospital of St. Gallen

Completed

Does the Management of Anastomotic Leakage After Low Rectal Resection Affect Survival (ISRECLeak)

Rectal Cancer | Anastomotic Leak

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC

Metastatic Castration-resistant Prostate Cancer

Switzerland
Hoffmann-La Roche
Sanofi-Synthélabo (Schweiz) AG

Completed

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Rectal Cancer

Switzerland
University of Zurich

Unknown

Zurich Fistula Cohort Study

Crohn Disease | Fistula;Rectal | Fistula; Rectouterine | Fistula; Rectovesical | Fistulas Recto Vaginal

Switzerland

Clinical Trials on Metastatic Rectum Cancer in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations